| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.45B | 24.46B | 22.74B | 20.72B | 19.82B | 17.22B |
| Gross Profit | 11.18B | 10.46B | 9.64B | 8.65B | 8.39B | 7.09B |
| EBITDA | 7.25B | 6.93B | 6.32B | 5.27B | 5.40B | 4.05B |
| Net Income | 4.13B | 4.06B | 3.76B | 3.05B | 3.14B | 2.02B |
Balance Sheet | ||||||
| Total Assets | 58.78B | 56.48B | 48.03B | 33.45B | 34.39B | 33.03B |
| Cash, Cash Equivalents and Short-Term Investments | 2.51B | 2.40B | 3.36B | 1.44B | 1.75B | 2.09B |
| Total Debt | 21.43B | 21.86B | 15.44B | 13.47B | 13.16B | 13.58B |
| Total Liabilities | 43.42B | 42.95B | 35.66B | 22.70B | 23.17B | 23.77B |
| Stockholders Equity | 15.15B | 13.34B | 12.19B | 10.52B | 11.01B | 9.10B |
Cash Flow | ||||||
| Free Cash Flow | 5.11B | 3.99B | 3.84B | 3.00B | 3.11B | 3.03B |
| Operating Cash Flow | 5.34B | 4.30B | 4.26B | 3.46B | 3.52B | 3.38B |
| Investing Cash Flow | -7.97B | -8.82B | -1.42B | -850.00M | -1.16B | -793.00M |
| Financing Cash Flow | 3.44B | 4.46B | -1.12B | -1.05B | -1.30B | -925.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $27.12B | 23.84 | 10.47% | 0.77% | 17.87% | -9.35% | |
74 Outperform | $89.79B | 21.98 | 28.62% | 1.85% | 10.57% | 2.57% | |
74 Outperform | $31.42B | 15.66 | 27.79% | 1.14% | ― | ― | |
73 Outperform | $13.22B | 23.08 | 30.44% | 1.90% | 9.64% | 15.87% | |
69 Neutral | $65.99B | 40.89 | 9.05% | 1.01% | 17.17% | 19.12% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $74.37B | 27.71 | 38.33% | 0.82% | 14.06% | 5.52% |
On January 14, 2026, Marsh & McLennan Companies, Inc. implemented amended and restated bylaws that update and align its governance framework with recent changes to the Delaware General Corporation Law, including provisions related to stockholder lists and quorum requirements for committee meetings. The revisions also tighten and clarify advance notice procedures for director nominations and other stockholder proposals—such as disclosure obligations, limits on the number of nominees, and incorporation of universal proxy rules—while specifying voting standards for matters submitted to shareholders and formalizing the authority of the chair at stockholder meetings, collectively reinforcing the company’s corporate governance structure and potentially shaping how investors engage with management and the board.
The most recent analyst rating on (MMC) stock is a Buy with a $208.00 price target. To see the full list of analyst forecasts on Marsh & Mclennan Companies stock, see the MMC Stock Forecast page.